Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 17;39(3):1279–1292. doi: 10.1007/s12325-021-02037-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Fig. 2 — Tornado diagram for the cost–utility analysis of an add-on dapagliflozin and standard of care for patients with CKD from a societal perspective over a lifetime horizon. CKD 3a chronic kidney disease stage 3a, CKD 3b chronic kidney disease stage 3b, CKD 4 chronic kidney disease stage 4, CKD 5 chronic kidney disease stage 5, Dapa dapagliflozin, ICER incremental cost-effectiveness ratio, KT kidney transplantation, Prob probability, QALY quality-adjusted life-year, THB Thai Baht